A citation-based method for searching scientific literature

Hao Yin, Chun-Qing Song, Sneha Suresh, Qiongqiong Wu, Stephen Walsh, Luke Hyunsik Rhym, Esther Mintzer, Mehmet Fatih Bolukbasi, Lihua Julie Zhu, Kevin Kauffman, Haiwei Mou, Alicia Oberholzer, Junmei Ding, Suet-Yan Kwan, Roman L Bogorad, Timofei Zatsepin, Victor Koteliansky, Scot A Wolfe, Wen Xue, Robert Langer, Daniel G Anderson. Nat Biotechnol 2017
Times Cited: 232



Kunwoo Lee, Michael Conboy, Hyo Min Park, Fuguo Jiang, Hyun Jin Kim, Mark A Dewitt, Vanessa A Mackley, Kevin Chang, Anirudh Rao, Colin Skinner, Tamanna Shobha, Melod Mehdipour, Hui Liu, Wen-Chin Huang, Freeman Lan, Nicolas L Bray, Song Li, Jacob E Corn, Kazunori Kataoka, Jennifer A Doudna, Irina Conboy, Niren Murthy. Nat Biomed Eng 2017
Times Cited: 358




List of shared articles



Times cited

CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.
Hanan Bloomer, Jennifer Khirallah, Yamin Li, Qiaobing Xu. Adv Drug Deliv Rev 2022
3

Drug delivery systems for RNA therapeutics.
Kalina Paunovska, David Loughrey, James E Dahlman. Nat Rev Genet 2022
28

Non-viral delivery of the CRISPR/Cas system: DNA versus RNA versus RNP.
Yi Lin, Ernst Wagner, Ulrich Lächelt. Biomater Sci 2022
5

Augmented lipid-nanoparticle-mediated in vivo genome editing in the lungs and spleen by disrupting Cas9 activity in the liver.
Cory D Sago, Melissa P Lokugamage, David Loughrey, Kevin E Lindsay, Robert Hincapie, Brandon R Krupczak, Sujay Kalathoor, Manaka Sato, Elisa Schrader Echeverri, Jordan P Fitzgerald,[...]. Nat Biomed Eng 2022
3


Nanoparticles-Mediated CRISPR/Cas Gene Editing Delivery System.
Phei Er Saw, Guo-Hui Cui, Xiaoding Xu. ChemMedChem 2022
1

CRISPR-Click Enables Dual-Gene Editing with Modular Synthetic sgRNAs.
Hansol Park, Eiman A Osman, Christopher R Cromwell, Chris D St Laurent, Yuning Liu, Elena N Kitova, John S Klassen, Basil P Hubbard, Matthew S Macauley, Julianne M Gibbs. Bioconjug Chem 2022
0


Pre-clinical non-viral vectors exploited for in vivo CRISPR/Cas9 gene editing: an overview.
Nadia Rouatbi, Tasneem McGlynn, Khuloud T Al-Jamal. Biomater Sci 2022
1

Rational designs of in vivo CRISPR-Cas delivery systems.
Cong-Fei Xu, Guo-Jun Chen, Ying-Li Luo, Yue Zhang, Gui Zhao, Zi-Dong Lu, Anna Czarna, Zhen Gu, Jun Wang. Adv Drug Deliv Rev 2021
53

Non-viral strategies for delivering genome editing enzymes.
Jie Li, Joachim Justad Røise, Maomao He, Riddha Das, Niren Murthy. Adv Drug Deliv Rev 2021
22


Next-Generation CRISPR Technologies and Their Applications in Gene and Cell Therapy.
M Alejandra Zeballos C, Thomas Gaj. Trends Biotechnol 2021
23

Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect.
Yu-Fan Chuang, Andrew J Phipps, Fan-Li Lin, Valerie Hecht, Alex W Hewitt, Peng-Yuan Wang, Guei-Sheung Liu. Cell Mol Life Sci 2021
13

Expanding the Potential of Mammalian Genome Engineering via Targeted DNA Integration.
Meng Zhang, Che Yang, Ipek Tasan, Huimin Zhao. ACS Synth Biol 2021
1

Co-encapsulation of Cas9 mRNA and guide RNA in polyplex micelles enables genome editing in mouse brain.
Saed Abbasi, Satoshi Uchida, Kazuko Toh, Theofilus A Tockary, Anjaneyulu Dirisala, Kotaro Hayashi, Shigeto Fukushima, Kazunori Kataoka. J Control Release 2021
17

The evolution and history of gene editing technologies.
Shubhchintan Randhawa, Shatakshi Sengar. Prog Mol Biol Transl Sci 2021
0

CRISPR-Cas9 in cancer therapeutics.
Shubhchintan Randhawa. Prog Mol Biol Transl Sci 2021
2


In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges.
Matthew Behr, Jing Zhou, Bing Xu, Hongwei Zhang. Acta Pharm Sin B 2021
20

Comparison of the Feasibility, Efficiency, and Safety of Genome Editing Technologies.
Nicolás González Castro, Jan Bjelic, Gunya Malhotra, Cong Huang, Salman Hasan Alsaffar. Int J Mol Sci 2021
7